Notice: This company has been marked as potentially delisted and may not be actively trading. NantKwest (NK) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Space Nk Promo CodesFebruary 4, 2024 | time.comFrankie Bridge shares her new Space NK beauty buys including concealer people 'love'August 13, 2023 | mirror.co.ukPiper Sandler Downgrades ImmunityBio (IBRX)May 13, 2023 | msn.comNantKwest Inc (IBRX) Earnings Dates & ReportsMay 12, 2023 | investing.comNK Cells Market Report | Research Across The World 2031May 10, 2023 | marketwatch.comNatural Killer Cell Therapy Market Size, Growth | Soaring Demand | 2023 - 2029March 9, 2023 | marketwatch.comNatural Killer Cell Therapy Market 2023 Statistics, Share Price, Growth Prospects, Industry Trends till 2028January 12, 2023 | marketwatch.comNK Cell Therapy Market Insights: Industry changing aspects, New Technologies and Forecast to 2025 | Market Growth ReportsNovember 26, 2022 | marketwatch.comNatural Killer Cells Therapeutics Market 2022 : Top Manufacturers, Key Trends, Progression Status and Business Trends to 2027September 29, 2022 | marketwatch.comNatural Killer Cell Therapy Market 2022 Production, Revenue, Growth Rate, Price and Gross Margin, Opportunities and Forecast 2026August 22, 2022 | marketwatch.comGlobal Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities - Yahoo FinanceAugust 12, 2022 | finance.yahoo.comGlobal Engineered T Cells Market Report 2022-2027: Increasing Demand for Innovative Biopharmaceutical The - BenzingaAugust 11, 2022 | benzinga.comHarpoon Therapeutics Expands Leadership Team - Yahoo FinanceJuly 6, 2022 | finance.yahoo.comCelldex (CLDX) Appoints Cheryl L. Cohen and Dr. Garry Neil to its Board - StreetInsider.comJune 18, 2022 | streetinsider.comCelldex Announces Two New Appointments to its Board of Directors - Yahoo FinanceJune 16, 2022 | finance.yahoo.comImmPACT Bio Names Sylvain Roy as Chief Technology Officer - PR NewswireMay 13, 2022 | prnewswire.comRAPT Therapeutics Expands Leadership Team with Multiple Key Hires - Yahoo FinanceMay 4, 2022 | finance.yahoo.comRAPT Therapeutics Expands Leadership Team with Multiple Key Hires - Marketscreener.comMay 4, 2022 | marketscreener.comList: the 17 Fastest-Growing Biotechs and Pharmas of 2021 - Business InsiderMarch 29, 2022 | businessinsider.comNatural Killer (NK) Cell Therapy Market Research Report 2022 - Comprehensive Insights about 100+ Companies and 185+ Pipeline Drugs - ResearchAndMarkets.com - Business WireMarch 10, 2022 | businesswire.comBiotechs face cash crunch after stock market ‘bloodbath’ - Financial TimesFebruary 10, 2022 | ft.comBladder Cancer Disease Market Analysis Research Report 2021 - ResearchAndMarkets.com - Business WireJanuary 29, 2022 | businesswire.comImmunityBio Announces Completion of $470 Million Post-merger Financing to Fund Late-stage Cancer Clinical Trials, Phase 3 of COVID T-Cell Universal Boost Vaccine Trial and Provides Update on Bladder Cancer BLA Filing - Yahoo FinanceDecember 20, 2021 | finance.yahoo.comAmbrx Biopharma Inc. Reports 1H 2021 Financial Results and Provides Corporate Update - Business WireOctober 29, 2021 | businesswire.comGlobal Natural Killer Cell Therapies Pipeline Insight Report 2021: 100+ Companies and 140+ Pipeline Drugs - ResearchAndMarkets.com - Business WireOctober 20, 2021 | businesswire.comFed. Circ. Removes Hyatt's Motives From Expert Fees Win - Law360October 12, 2021 | law360.comFed. Circ. Denies USPTO's Bid For Expert Fees From Inventor - Law360August 18, 2021 | law360.comFed Circ says inventor doesn't owe PTO's expert fees in patent appeal - ReutersAugust 18, 2021 | reuters.comAnalyzing Tattooed Chef's Unusual Options ActivityAugust 13, 2021 | benzinga.com Get NantKwest News Delivered to You Automatically Sign up to receive the latest news and ratings for NK and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol NK Media Mentions By Week NK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NK News Sentiment▼0.000.60▲Average Medical News Sentiment NK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NK Articles This Week▼00▲NK Articles Average Week Get NantKwest News Delivered to You Automatically Sign up to receive the latest news and ratings for NK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VIR News ADPT News PSTX News IMTX News LENZ News REPL News RLAY News AVXL News AUTL News CGEM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NK) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NantKwest, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NantKwest With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.